RaNA Therapeutics Receives $55,000,000 Series B Funding Round

  • Feed Type
  • Date
    7/23/2015
  • Company Name
    RaNA Therapeutics
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139 USA
  • Company Description
    RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA’s technology upregulates the expression of desirable genes that can prevent or treat disease.
  • Website
    http://www.ranarx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    RaNA is expanding its R&D footprint in hopes of identifying new candidates in oncology, inflammation and other diseases.
  • M&A Terms
  • Venture Investor
    The Baupost Group
  • Venture Investor
    Merck Capital Ventures
  • Venture Investor
    Brookside Capital
  • Venture Investor
    Leerink Partners
  • Venture Investor
    Accomplice
  • Venture Investor
    Monsanto
  • Venture Investor
    Omega Funds
  • Venture Investor
    Partners Innovation Fund
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    SR One

Trending on Xconomy